Annual EBITDA
-$68.74 M
+$23.88 M+25.78%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual EBITDA is -$68.74 million, with the most recent change of +$23.88 million (+25.78%) on December 31, 2023.
- During the last 3 years, EIGR annual EBITDA has fallen by -$7.93 million (-13.04%).
- EIGR annual EBITDA is now -3110.70% below its all-time high of -$2.14 million, reached on December 1, 2011.
Performance
EIGR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$11.85 M
+$4.57 M+27.86%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly EBITDA is -$11.85 million, with the most recent change of +$4.57 million (+27.86%) on December 31, 2023.
- Over the past year, EIGR quarterly EBITDA has increased by +$11.86 million (+50.03%).
- EIGR quarterly EBITDA is now -139.04% below its all-time high of $30.35 million, reached on March 31, 2021.
Performance
EIGR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$68.74 M
+$11.86 M+14.71%
December 31, 2023
Summary
- As of February 12, 2025, EIGR TTM EBITDA is -$68.74 million, with the most recent change of +$11.86 million (+14.71%) on December 31, 2023.
- Over the past year, EIGR TTM EBITDA has increased by +$23.04 million (+25.10%).
- EIGR TTM EBITDA is now -2452.58% below its all-time high of -$2.69 million, reached on June 30, 2016.
Performance
EIGR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EIGR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.8% | +50.0% | +25.1% |
| 3 y3 years | -13.0% | +33.1% | -13.0% |
| 5 y5 years | -37.5% | +24.7% | -3.6% |
EIGR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -133.1% | +25.8% | at high | +54.1% | -133.1% | +25.1% |
| 5 y | 5-year | -133.1% | +25.8% | -139.0% | +54.1% | -322.7% | +25.1% |
| alltime | all time | -3110.7% | +25.8% | -139.0% | +54.1% | -2452.6% | +25.1% |
Eiger BioPharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$68.74 M(-25.8%) | -$11.85 M(-27.9%) | -$68.74 M(-14.7%) |
| Sep 2023 | - | -$16.42 M(-14.3%) | -$80.60 M(-10.4%) |
| Jun 2023 | - | -$19.17 M(-10.0%) | -$89.99 M(-1.7%) |
| Mar 2023 | - | -$21.31 M(-10.1%) | -$91.54 M(-0.3%) |
| Dec 2022 | -$92.62 M(+214.0%) | -$23.70 M(-8.1%) | -$91.78 M(+3.4%) |
| Sep 2022 | - | -$25.81 M(+24.5%) | -$88.73 M(+5.6%) |
| Jun 2022 | - | -$20.72 M(-3.8%) | -$84.04 M(+3.3%) |
| Mar 2022 | - | -$21.54 M(+4.3%) | -$81.38 M(+175.9%) |
| Dec 2021 | -$29.50 M(-51.5%) | -$20.65 M(-2.2%) | -$29.50 M(+11.1%) |
| Sep 2021 | - | -$21.12 M(+16.9%) | -$26.56 M(+32.4%) |
| Jun 2021 | - | -$18.07 M(-159.5%) | -$20.05 M(+23.3%) |
| Mar 2021 | - | $30.35 M(-271.3%) | -$16.26 M(-73.3%) |
| Dec 2020 | -$60.81 M(-8.4%) | -$17.71 M(+21.2%) | -$60.81 M(+3.1%) |
| Sep 2020 | - | -$14.61 M(+2.3%) | -$58.98 M(-4.8%) |
| Jun 2020 | - | -$14.28 M(+0.5%) | -$61.99 M(-3.5%) |
| Mar 2020 | - | -$14.20 M(-10.6%) | -$64.25 M(-3.2%) |
| Dec 2019 | -$66.36 M(+32.7%) | -$15.89 M(-9.8%) | -$66.36 M(+0.2%) |
| Sep 2019 | - | -$17.62 M(+6.5%) | -$66.20 M(+1.8%) |
| Jun 2019 | - | -$16.54 M(+1.4%) | -$65.03 M(+12.3%) |
| Mar 2019 | - | -$16.31 M(+3.7%) | -$57.90 M(+15.8%) |
| Dec 2018 | -$50.01 M | -$15.73 M(-4.4%) | -$50.01 M(+11.7%) |
| Sep 2018 | - | -$16.45 M(+74.8%) | -$44.77 M(+20.7%) |
| Jun 2018 | - | -$9.41 M(+11.7%) | -$37.09 M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$8.42 M(-19.7%) | -$38.44 M(-6.0%) |
| Dec 2017 | -$40.88 M(-11.8%) | -$10.49 M(+19.6%) | -$40.88 M(-5.3%) |
| Sep 2017 | - | -$8.77 M(-18.5%) | -$43.15 M(-5.7%) |
| Jun 2017 | - | -$10.76 M(-1.0%) | -$45.74 M(-5.1%) |
| Mar 2017 | - | -$10.87 M(-14.8%) | -$48.18 M(+3.9%) |
| Dec 2016 | -$46.37 M(+257.8%) | -$12.76 M(+12.2%) | -$46.37 M(+402.6%) |
| Sep 2016 | - | -$11.36 M(-13.9%) | -$9.23 M(+242.6%) |
| Jun 2016 | - | -$13.20 M(+45.7%) | -$2.69 M(-51.0%) |
| Mar 2016 | - | -$9.06 M(-137.1%) | -$5.50 M(-56.4%) |
| Dec 2015 | -$12.96 M(-60.7%) | $24.39 M(-604.9%) | -$12.60 M(-73.7%) |
| Sep 2015 | - | -$4.83 M(-69.8%) | -$47.88 M(-6.3%) |
| Jun 2015 | - | -$16.00 M(-1.0%) | -$51.09 M(+21.5%) |
| Mar 2015 | - | -$16.16 M(+48.4%) | -$42.04 M(+27.6%) |
| Dec 2014 | -$32.96 M(+65.1%) | -$10.89 M(+35.5%) | -$32.96 M(+17.0%) |
| Sep 2014 | - | -$8.04 M(+15.5%) | -$28.17 M(+10.2%) |
| Jun 2014 | - | -$6.96 M(-1.7%) | -$25.57 M(+8.7%) |
| Mar 2014 | - | -$7.08 M(+16.0%) | -$23.53 M(+17.9%) |
| Dec 2013 | -$19.96 M(+27.2%) | -$6.10 M(+12.2%) | -$19.96 M(+44.0%) |
| Sep 2013 | - | -$5.44 M(+10.7%) | -$13.86 M(+64.5%) |
| Jun 2013 | - | -$4.91 M(+39.9%) | -$8.43 M(+139.9%) |
| Mar 2013 | - | -$3.51 M | -$3.51 M |
| Dec 2012 | -$15.70 M(+633.3%) | - | - |
| Dec 2011 | -$2.14 M(-63.0%) | - | - |
| Jun 2011 | -$5.79 M | - | - |
FAQ
- What is Eiger BioPharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual EBITDA year-on-year change?
- What is Eiger BioPharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly EBITDA year-on-year change?
- What is Eiger BioPharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals TTM EBITDA year-on-year change?
What is Eiger BioPharmaceuticals annual EBITDA?
The current annual EBITDA of EIGR is -$68.74 M
What is the all time high annual EBITDA for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual EBITDA is -$2.14 M
What is Eiger BioPharmaceuticals annual EBITDA year-on-year change?
Over the past year, EIGR annual EBITDA has changed by +$23.88 M (+25.78%)
What is Eiger BioPharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of EIGR is -$11.85 M
What is the all time high quarterly EBITDA for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly EBITDA is $30.35 M
What is Eiger BioPharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, EIGR quarterly EBITDA has changed by +$11.86 M (+50.03%)
What is Eiger BioPharmaceuticals TTM EBITDA?
The current TTM EBITDA of EIGR is -$68.74 M
What is the all time high TTM EBITDA for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high TTM EBITDA is -$2.69 M
What is Eiger BioPharmaceuticals TTM EBITDA year-on-year change?
Over the past year, EIGR TTM EBITDA has changed by +$23.04 M (+25.10%)